DuPont de Nemours, Inc (DD) Fair Value & Analysis
Basic Materials · US · Market cap $19.3B
DuPont de Nemours, Inc
DD · US
Fair value as of: Jun 24, 2026
From 16 valuation models · updated 5 days ago
Share price +180.3% over the past month.
Price vs Fair Value (12 months)
12‑month range $29.06 – $144.41 · fair‑value band $18.62 – $34.77 · the $140.01 price screens above the $26.57 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
DuPont de Nemours, Inc (DD) currently trades at $140.01, while our model-based Fair Value estimate is $26.57 — implying the stock looks roughly 81.0% overvalued today. We read business quality at 94/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, DuPont de Nemours, Inc generated revenue of $6.9B at a net margin of -0.4%. Revenue grew 4.3% year over year. It earns a return on equity of 0.9%. Net debt stands at $2.4B. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORI…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
DuPont de Nemours, Inc reported revenue of $6.8B in FY2025 versus $12.6B in FY2021, a compound −14.1%/yr. Reported net income was −$779M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $516.71 | $221.55 | -57% |
| L'Air Liquide S.A AIQUY | $37.81 | $15.56 | -59% |
| Air Products and Chemicals, Inc A1PD34 | R$364.32 | R$50.60 | -86% |
| Intercontinental Exchange, Inc I1CE34 | R$359.64 | R$307.76 | -14% |
| Wanhua Chemical Group 600309 | ¥72.46 | ¥51.34 | -29% |
| Asian Paints Limited ASIANPAINT | ₹2,674 | ₹739.38 | -72% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is DuPont de Nemours, Inc (DD) undervalued?
What is the fair value of DD?
What is the quality score of DD?
What is the revenue of DuPont de Nemours, Inc (DD)?
What is the net profit margin of DD?
Does DuPont de Nemours, Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.